These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
163 related items for PubMed ID: 27072942
21. Impact of age on outcomes following continuous-flow left ventricular assist device implantation. Lushaj EB, Badami A, Osaki S, Murray M, Leverson G, Lozonschi L, Akhter S, Kohmoto T. Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):743-8. PubMed ID: 25770085 [Abstract] [Full Text] [Related]
22. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables. John R, Pagani FD, Naka Y, Boyle A, Conte JV, Russell SD, Klodell CT, Milano CA, Rogers J, Farrar DJ, Frazier OH. J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659 [Abstract] [Full Text] [Related]
23. Outcomes and hospital admissions during long-term support with a HeartMate II. Rossing K, Jung MH, Sander K, Olsen PS, Hansen PB, Boesgaard S, Gustafsson F. Scand Cardiovasc J; 2015 Jul; 49(6):367-75. PubMed ID: 26400060 [Abstract] [Full Text] [Related]
24. Clinical Significance of Early Hospital Readmission in Continuous-Flow Left Ventricular Assist Device Patients. Kutyifa V, Naqvi SY, Vidula H, Thomas S, Sherazi S, McNitt S, Alexis JD. ASAIO J; 2020 Jul; 66(7):760-765. PubMed ID: 31453834 [Abstract] [Full Text] [Related]
25. Psychosocial Evaluation in Patients Undergoing Left Ventricular Assist Device Implantation Using the Transplant Evaluation Rating Scale. Yost GL, Bhat G, Ibrahim KN, Karountzos AG, Chandrasekaran M, Mahoney E. Psychosomatics; 2016 Jul; 57(1):41-6. PubMed ID: 26481959 [Abstract] [Full Text] [Related]
26. Discharge outcomes in patients with paracorporeal biventricular assist devices. Thomas SS, Smallwood J, Smith CM, Griffin LM, Shekar P, Chen FY, Couper GS, Givertz MM. Ann Thorac Surg; 2014 Mar; 97(3):894-900. PubMed ID: 24280185 [Abstract] [Full Text] [Related]
27. Intensive Care Unit Readmission After Left Ventricular Assist Device Implantation: Causes, Associated Factors, and Association With Patient Mortality. Hui J, Mauermann WJ, Stulak JM, Hanson AC, Maltais S, Barbara DW. Anesth Analg; 2019 Jun; 128(6):1168-1174. PubMed ID: 31094784 [Abstract] [Full Text] [Related]
28. Readmission Patterns During Long-Term Follow-Up After Left Ventricular Assist Device Implantation. Vidula H, Kutyifa V, Johnson BA, Strawderman RL, Harrington D, Polonsky B, Papernov A, Alexis JD. Am J Cardiol; 2018 Sep 15; 122(6):1021-1027. PubMed ID: 30064855 [Abstract] [Full Text] [Related]
36. Hospital costs for left ventricular assist devices for destination therapy: lower costs for implantation in the post-REMATCH era. Miller LW, Nelson KE, Bostic RR, Tong K, Slaughter MS, Long JW. J Heart Lung Transplant; 2006 Jul 15; 25(7):778-84. PubMed ID: 16818120 [Abstract] [Full Text] [Related]
37. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy. John R, Kamdar F, Liao K, Colvin-Adams M, Boyle A, Joyce L. Ann Thorac Surg; 2008 Oct 15; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167 [Abstract] [Full Text] [Related]
39. Long-term use of left ventricular assist devices: a report on clinical outcomes. Raju S, MacIver J, Foroutan F, Alba C, Billia F, Rao V. Can J Surg; 2017 Aug 15; 60(4):236-246. PubMed ID: 28730986 [Abstract] [Full Text] [Related]